Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Considerations for Initiating ADT in Prostate Cancer

March 13th 2018

Eisai And Merck to Collaborate on Lenvatinib Mesylate

March 9th 2018

Lenvatinib mesylate (Lenvima) will be developed and commercialized in a collaboration between its creator, Japan’s Eisai Co. Ltd, and Merck.

Is Your Practice Ready for New Rules on Hazardous Drug Management

March 3rd 2018

Among community oncology practices, the US Pharmacopeia Convention’s General Chapter draft guidelines have already raised the bar for hazardous drug management and imposed costs for compliance.

Pearls of Wisdom for the Field of NSCLC

March 1st 2018

Sequencing Therapies for ALK-Rearranged NSCLC

March 1st 2018

New Standard of Care for ALK-Rearranged NSCLC

March 1st 2018

Ongoing Research in EGFR+ NSCLC

March 1st 2018

Treatment of EGFR+ NSCLC Brain Metastases

March 1st 2018

New Standard for Treating Stage 4 EGFR+ NSCLC

March 1st 2018

Biomarkers for Selection of Immuno-Oncology Agents in NSCLC

March 1st 2018

Dual Checkpoint Inhibitor Therapy for NSCLC

March 1st 2018

Quadruple Therapy for Newly Diagnosed NSCLC

March 1st 2018

Immuno-Oncology Combination Therapy: Which Patients With NSCLC?

March 1st 2018

Pembrolizumab + Chemotherapy in Newly Diagnosed NSCLC

March 1st 2018

Checkpoint Inhibitors for Newly Diagnosed Stage 4 NSCLC

March 1st 2018

Potential for Use of Checkpoint Inhibitors in Early-Stage NSCLC

March 1st 2018

Surgery in the Context of Immunotherapy for Locally Advanced NSCLC

March 1st 2018

Treatment of Unresectable Locally Advanced NSCLC

March 1st 2018

Treatment of Operable Locally Advanced NSCLC

March 1st 2018

Improving Outcomes in CRC

February 26th 2018